Diabetes during the COVID-19 pandemic: A global call to reconnect with patients and emphasize lifestyle changes and optimize glycemic and blood pressure control.

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

Who cites it

13 citing papers in PubMed, 1 synthesis or guideline pooled it.

1. The use of renin angiotensin system inhibitor on mortality in patients with coronavirus disease 2019 (COVID-19): A systematic review and meta-analysis.Diabetes & metabolic syndrome
   Pooled it
2. Internal factors related to self-management among type 2 diabetes patients during the COVID-19 pandemic as humanitarian emergencies: a scoping review protocol.Systematic reviews · 2025
   Article
3. Preserved seasonal variation in glycemic control in patients with type 2 diabetes mellitus during COVID-19: a 3-year-long retrospective cohort study in older adults in Japan.BMC endocrine disorders · 2024
   Article
4. Expert Opinion: Optimum Clinical Approach to Combination-Use of SGLT2i + DPP4i in the Indian Diabetes Setting.Diabetes therapy : research, treatment and education of diabetes and related disorders · 2022
   Article
5. The burden of type 2 diabetes pre-and during the COVID-19 pandemic - a review.Journal of diabetes and metabolic disorders · 2020
   Article
6. The early impact of the COVID-19 pandemic on adults with type 1 or type 2 diabetes: A national cohort study.Journal of diabetes and its complications · 2020
   Article
7. COVID-19 in people living with diabetes: An international consensus.Journal of diabetes and its complications · 2020
   Review
8. Cardiometabolic vigilance in COVID-19 and resource husbandry in resource-challenged times: Clinical practice- based expert opinion.Diabetes & metabolic syndrome
   Review
9. Impact of COVID-19 and comorbidities on health and economics: Focus on developing countries and India.Diabetes & metabolic syndrome
   Review
10. [Impact of the alteration of the continuity of care in diabetes type 2 patients during the COVID-19 pandemic].Semergen
    Article
11. Hypercoagulable state in COVID-19 with diabetes mellitus and obesity: Is therapeutic-dose or higher-dose anticoagulant thromboprophylaxis necessary?Diabetes & metabolic syndrome
    Article
12. Association of hypertension and diabetes with COVID-19 severity in comparison to healthy patients.Journal of circulating biomarkers
    Article
13. Strict glycemic control is needed in times of COVID19 epidemic in India: A Call for action for all physicians.Diabetes & metabolic syndrome
    Article

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

Authors and funding

2 authors.

Funding

No grant is acknowledged in the PubMed record.

Abstract

PubMed holds no abstract for this paper.

Indexed as